Неврология, нейропсихиатрия, психосоматика (Apr 2021)

COVID-19 vaccination guidelines for patients with multiple sclerosis

  • N. V. Khachanova,
  • N. A. Totolyan,
  • Ya. V. Vlasov,
  • S. A. Sivertseva,
  • M. V. Davydovskaya,
  • E. P. Evdoshenko,
  • A. P. Prodeus,
  • M. N. Zakharova,
  • N. N. Spirin,
  • A. N. Boyko

DOI
https://doi.org/10.14412/2074-2711-2021-2-157-161
Journal volume & issue
Vol. 13, no. 2
pp. 157 – 161

Abstract

Read online

The opinion of Russian experts on the possibility of COVID-19 vaccination in patients with multiple sclerosis (MS) is presented. The authors of the consensus, based on an analysis of a large number of domestic and foreign guidelines, conclude that it is possible to use killed and inactivated vaccines. Preliminary recommendations are given for COVID-19 vaccination, taking into account the MS disease modifying therapies.

Keywords